Skip to main content

Table 3 Medications with decreased consumption found in the number of people in the IG

From: Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people

  Number of people taking medications Difference Percentage
Generic name A. 2019 B. 2020 C. A-B C/A
Magnesium Oxidea 118 43 75 63.6%
Furosemidea 57 40 17 29.8%
Spironolactonea 41 25 16 39.0%
Sennoside 41 28 13 31.7%
White Vaseline 17 5 12 70.6%
Butyric acid bacteria 24 13 11 45.8%
Amlodipine 57 47 10 17.5%
Dimethylisopropyl azulene 15 5 10 66.7%
Famotidinea 13 3 10 76.9%
Azithromycin 9 0 9 100.0%
Ambroxol 11 2 9 81.8%
Ketoprofena 13 4 9 69.2%
Loxoprofena 16 7 9 56.3%
Liver-Inhibiting Powder plus Tangerine Peel, Pinellia Tuber 9 0 9 100.0%
Oseltamivir 8 0 8 100.0%
  1. a Generic name listed in “Guidelines for medical treatment and its safety in older people 2015”
  2. IG (improvement group), the participants who were prescribed PIMs in March 2019 and those who were not prescribed PIMs in March 2020
  3. The study period was between March 2019 and March 2020